Table 2 Response and survival data
Taxane combined platinum-based concurrent chemoradiotherapy | |
|---|---|
Response at 3 months post radiotherapy* | N = 102 |
Objective Response | 102 (100.0%) |
Disease control | 102 (100.0%) |
Complete response | 86 (88.3%) |
Partial response | 17 (16.7%) |
Stable disease | 0 (0.0%) |
Progressive disease | 0 (0.0%) |
Response at 6 months post radiotherapy | N = 104 |
Objective response | 104 (100.0%) |
Disease control | 104 (100.0%) |
Complete response | 103 (99.0%) |
Partial response | 1 (1.0%) |
Stable disease | 0 (0.0%) |
Progressive disease | 0 (0.0%) |